Xalkori and Tylenol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Xalkori (crizotinib) and Tylenol (acetaminophen). Common drug interactions include musculoskeletal stiffness among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Xalkori and Tylenol. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Xalkori?

Xalkori has active ingredients of crizotinib. eHealthMe is studying from 9,659 Xalkori users. Check the latest studies of Xalkori.

What is Tylenol?

Tylenol has active ingredients of acetaminophen. It is often used in pain. eHealthMe is studying from 222,310 Tylenol users. Check the latest studies of Tylenol.



On Aug, 08, 2026

92 people who take Xalkori and Tylenol together, and have interactions are studied.

Xalkori and Tylenol drug interactions.

What are the common drug interactions of Xalkori and Tylenol, by gender? *:

female:

  1. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  2. Skin tightness
  3. Pneumonia
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Visual impairment
  6. Decreased appetite
  7. Fall
  8. Neuropathy peripheral (surface nerve damage)
  9. Non-small cell lung cancer metastatic (type of epithelial lung cancer spreads to other parts)
  10. Lymphadenopathy (disease or enlargement of lymph nodes)

male:

  1. Nausea (feeling of having an urge to vomit)
  2. Fatigue (feeling of tiredness)
  3. Asthenia (weakness)
  4. Bradycardia (abnormally slow heart action)
  5. Dyspnoea (difficult or laboured respiration)
  6. Abdominal pain
  7. Pneumonia
  8. Cough
  9. Disease progression
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Xalkori and Tylenol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal pain
  2. Back pain
  3. Decreased appetite
  4. Diarrhoea
  5. Fatigue (feeling of tiredness)
  6. Local swelling (swelling at the site of some application of substance or injury)
  7. Nausea (feeling of having an urge to vomit)
  8. Neoplasm progression (growth of tumour)
  9. Oedema peripheral (superficial swelling)
  10. Vomiting

40-49:

  1. Fatigue (feeling of tiredness)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Alanine aminotransferase increased
  5. Asthenia (weakness)
  6. Constipation
  7. Muscle spasms (muscle contraction)
  8. Nasopharyngitis (inflammation of the nasopharynx)
  9. Pulmonary embolism (blockage of the main artery of the lung)
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

50-59:

  1. Neuropathy peripheral (surface nerve damage)
  2. Oedema peripheral (superficial swelling)
  3. Oropharyngeal pain
  4. Periorbital oedema (swelling around the eyes)
  5. Photophobia (extreme sensitivity to light)
  6. Sensation of foreign body
  7. Visual impairment
  8. Vomiting
  9. Chest pain
  10. Hepatic enzyme increased

60+:

  1. Diarrhoea
  2. Nausea (feeling of having an urge to vomit)
  3. Dizziness
  4. Hypotension (abnormally low blood pressure)
  5. Decreased appetite
  6. Vomiting
  7. Influenza
  8. Lower limb fracture
  9. Bradycardia (abnormally slow heart action)
  10. Constipation

What are the existing conditions these people have? *

  1. Lung Neoplasm Malignant (cancer tumour of lung): 36 people, 39.13%
  2. Lung Cancer - Non-Small Cell (lung cancer): 16 people, 17.39%
  3. Nausea (feeling of having an urge to vomit): 15 people, 16.30%
  4. Cough: 9 people, 9.78%
  5. Wheezing (a high-pitched whistling sound made while you breath): 8 people, 8.70%
  6. Lung Adenocarcinoma Stage Iv (the cancer has spread to other organs of the body, such as the other lung, brain, or liver): 7 people, 7.61%
  7. Fever: 6 people, 6.52%
  8. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 5.43%
  9. Dyspnea (difficult or laboured breathing): 5 people, 5.43%
  10. Constipation: 5 people, 5.43%

* Approximation only. Some reports may have incomplete information.

Do you take Xalkori and Tylenol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Xalkori and Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Xalkori:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Tylenol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xalkori and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tylenol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on crizotinib and acetaminophen (the active ingredients of Xalkori and Tylenol, respectively), and Xalkori and Tylenol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: